Thalidomide-NH-C6-NH2 is primarily utilized in the field of medicinal chemistry for its potential therapeutic applications. It is being investigated for its role in modulating immune responses and inhibiting angiogenesis, making it a candidate for treating certain cancers and autoimmune diseases. Additionally, its structural modifications allow for targeted drug delivery, enhancing its efficacy and reducing side effects. Researchers are also exploring its use in combination therapies to improve outcomes in conditions like multiple myeloma and leprosy. Its unique properties make it a valuable compound in the development of novel treatments for complex diseases.